Systematic review: Sphincter of Oddi dysfunction - Non-invasive diagnostic methods and long-term outcome after endoscopic sphincterotomy

Alimentary Pharmacology and Therapeutics

Volumn 24, Issue 2, 2006, Pages 237-246

  Sgouros, S N ^a   Pereira, S P ^a,b  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; MORPHINE; NEOSTIGMINE; NIFEDIPINE; NITRIC ACID DERIVATIVE; OCTREOTIDE; SECRETIN;

CLINICAL TRIAL; DIAGNOSTIC ACCURACY; ELECTROSTIMULATION THERAPY; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC SPHINCTEROTOMY; HEPATOBILIARY SCINTISCANNING; HUMAN; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MANOMETRY; NON INVASIVE MEASUREMENT; PRIORITY JOURNAL; PROVOCATION TEST; REVIEW; SENSITIVITY AND SPECIFICITY; STENT; VATER PAPILLA STENOSIS;

COMMON BILE DUCT DISEASES; HUMANS; SPHINCTER OF ODDI; SPHINCTEROTOMY, ENDOSCOPIC;

EID: 33745642083     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2006.02971.x     Document Type: Review

References (77)

1. Corazziari E, Shaffer EA, Hogan W, Sherman S, Toouli J. Functional disorders of the biliary tract and pancreas. Gut 1999; 45 (Suppl. 2): 48-54.
2. Black NA, Thompson E, Sanderson CFB. Symptoms and health status before and six weeks after open cholecystectomy: a European cohort study. ECHSS Group. European Collaborative Health Services Study Group. Gut 1994; 35: 1301-5.
3. Choudhry U, Ruffolo T, Jamidar P, Hawes R, Lehman G. Sphincter of Oddi dysfunction in patients with intact gallbladder: therapeutic response to endoscopic sphincterotomy. Gastrointest Endosc 1993; 39: 492-5.
4. Hogan WJ, Sherman S, Pasricha P, Carr-Locke DL. Sphincter of Oddi manometry. Gastrointest Endosc 1997; 45: 342-8.
5. Eversman D, Fogel EL, Rusche M, Sherman S, Lehman GA. Frequency of abnormal pancreatic and biliary sphincter manometry compared with clinical suspicion of sphincter of Oddi dysfunction. Gastrointest Endosc 1999; 50: 637-41.
6. Steinberg WM. Sphincter of Oddi dysfunction: a clinical controversy. Gastroenterology 1988; 95: 1409-15.
7. Lin OS, Soetikno RM, Young HS. The utility of liver function test abnormalities concomitant with biliary symptoms in predicting a favorable response to endoscopic sphincterotomy in patients with presumed sphincter of Oddi dysfunction. Am J Gastroenterol 1998; 93: 1833-6.
8. Freeman ML, Nelson DB, Sherman S, et al. Complications of endoscopic biliary sphincterotomy. N Engl J Med 1996; 35: 909-8.
9. Freeman ML, Nelson DB, Sherman S, et al. The role of ERCP in diseases of the biliary tract and pancreas: guidelines for clinical application. Gastrointest Endosc 1999; 50: 915-20.
10. Sherman S, Ruffolo T, Hawes RH. Complications of endoscopic sphincterotomy: a prospective series with emphasis on the increased risk associated with sphincter of Oddi dysfunction and non-dilated bile ducts. Gastroenterology 1991; 101: 1068-75.
11. Chen YK, Foliente RL, Santoro MJ, Walter MH, Collen MJ. Endoscopic sphincterotomy-induced pancreatitis: increased risk associated with nondilated bile ducts and sphincter of Oddi dysfunction. Am J Gastroenterol 1994; 89: 327-33.
12. Freeman M, DiSario JA, Nelson DB, et al. Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointest Endosc 2000; 54: 425-34.
13. Cheng CL, Sherman S, Watkins JL, et al. Risk factors for post-ERCP pancreatitis: a prospective multicenter study. Am J Gastroenterol 2006; 101: 139-47.
14. Guelrud M, Mendoza S, Guillermo R, Villages MI. Sphincter of Oddi manometry in healthy volunteers. Dig Dis Sci 1990; 35: 38-46.
15. Steinberg WM, Salvato RF, Toskes PP. The morphine-prostigmin provocative test: is it useful for making clinical decisions? Gastroenterology 1980; 78: 728-31.
16. Cavallini G, Rigo L, Bovo P, et al. Abnormal US response of the main pancreatic duct after secretin stimulation in patients with acute pancreatitis of different etiology. J Clin Gastroenterol 1994; 18: 298-303.
17. Rosenblatt ML, Catalano MF, Alcocer E, Geenen JE. Comparison of sphincter of Oddi manometry, fatty meal sonography and hepatobiliary scintigraphy in the diagnosis of sphincter of Oddi dysfunction. Gastrointest Endosc 2001; 54: 697-704.
18. Hadidi A. Pancreatic duct diameter: sonographic measurement in normal subjects. J Clin Ultrasound 1983; 11: 17-22.
19. Catalano MF, Lahoti S, Alcocer E, Geenen JE, Hogan WJ. Dynamic imaging of the pancreas using real-time endoscopic ultrasonography with secretin stimulation. Gastrointest Endosc 1998; 48: 580-7.
20. Barish MA, Yucel EK, Ferrucci JT. Magnetic resonance cholangiopancreatography. N Engl J Med 1999; 341: 258-64.
21. Alpini G, Glaser S, Robertson W, et al. Large but not small intrahepatic bile ducts are involved in secretin-regulated ductal bile secretion. Am J Physiol 1997; 272: G1064-71.
22. Czako L, Takacs T, Morvay Z, Csernay L, Lonovics J. Diagnostic role of secretin-enhanced MRCP in patients with unsuccessful ERCP. World J Gastroenterol 2004; 15: 3034-8.
23. Kalayci C, Choudari CP, Sherman S, et al. Correlation of secretin stimulated MRCP findings with sphincter of Oddi manometry. Gastrointest Endosc 1999; 49: 79A (abstract).
24. Devereaux BM, Fogel EL, Aisen A, et al. Secretin-stimulated functional MRCP: correlation with sphincter of Oddi manometry. Gastrointest Endosc 2000; 51: A197 (abstract).
25. Mariani A, Curioni S, Zanello A, et al. Secretin MRCP and endoscopie pancreatic manometry in the evaluation of sphincter of Oddi function: a comparative pilot study in patients with idiopathic recurrent pancreatitis. Gastrointest Endosc 2003; 58: 847-52.
26. Pereira SP, Gillams A, Sgouros SN, Webster GJM, Hatfield ARW. Long term outcome of patients with sphincter of Oddi dysfunction after endoscopie sphincterotomy; a prospective study. Gut 2006; 55 (Suppl. II): A60 (abstract).
27. Darweesh RM, Dodds WJ, Hogan WJ, et al. Efficacy of quantitative hepatobiliary scintigraphy and fatty-meal sonography for evaluating patients with suspected partial common duct obstruction. Gastroenterology 1988; 94: 779-86.
28. Zeman RK, Burrell M, Dobbins J, et al. Postcholecystectomy syndrome: evaluation using biliary scintigraphy and endoscopie retrograde cholangiopancreatography. Radiology 1985; 156: 787-92.
29. Shaffer EA, Hershfield NB, Logan K, et al. Cholescintigraphic detection of functional obstruction of the sphincter of Oddi: effect of papillotomy. Gastroenterology 1986; 90: 728-33.
30. Grimon G, Buffet C, Andre L, Etienne JP, Desgrez A. Biliary pain in postcholecystectomy patients without biliary obstruction: a prospective randomised study. Dig Dis Sci 1991; 36: 317-20.
31. Fullarton GM, Allan A, Hilditch T, et al. Quantitative 99mTc-DISIDA scanning and endoscopic biliary manometry in sphincter of Oddi dysfunction. Gut 1988; 29: 1397-40.
32. Farup PG, Tjora S. Sphincter of Oddi dysfunction: dynamic cholescintigraphy and endoscopic retrograde cholangiopancreatography with papillotomy in diagnosis, treatment and follow-up study. Scand J Gastroenterol 1989; 24: 956-60.
33. Sostre S, Kalloo AN, Spiegler EI, et al. A non-invasive test of sphincter of Oddi dysfunction in postcholecystectomy patients: the scintigraphic score. J Nucl Med 1992; 33: 1216-22.
34. Pineau BC, Knapple WL, Spicer KM, et al. Cholecystokinin stimulated mebrofinin (99mTc-Choletec) hepatobiliary scintigraphy in asymptomatic post-cholecystectomy individuals: assessment of specificity interobserver reliability and reproducibility. Am J Gastroenterol 2001; 97: 3106-9.
35. Cicala M, Scopinaro F, Corazziari E, et al. Quantitative cholescintigraphy in the assessment of choledochoduodenal bile flow. Gastroenterology 1991; 100: 1106-13.
36. Corazziari E, Cicala M, Habib FI, et al. Hepatoduodenal bile transit in cholecystectomized subjects: relationship with sphincter of Oddi function and diagnostic value. Dig Dis Sci 1994; 39: 1985-93.
37. Madacsy L, Middelfart HV, Matzen P, et al. Quantitative hepatobiliary scintigraphy and endoscopie sphincter of Oddi dysfunction: assessment of flow pressure relationship in the biliary tract. Eur J Gastroenterol Hepatol 2000; 12: 777-86.
38. Craig AG, Peter D, Saccone GTP, et al. Scintigraphy versus manometry in patients with suggested biliary sphincter of Oddi dysfunction. Gut 2003; 52: 352-7.
39. Thomas PD, Turner JG, Dobbs BR, Burt MJ, Chapman BA. Use of 99mTc-DISIDA biliary scanning with morphine provocation in the detection of elevated sphincter of Oddi basal pressure. Gut 2000; 46: 838-41.
40. Cicala M, Habib FI, Vavassori P, et al. Outcome of endoscopic sphincterotomy in post cholecystectomy patients with sphincter of Oddi dysfunction as predicted by manometry and quantitative choledochoscintigraphy. Gut 2002; 50: 665-8.
41. Guelrud M, Mendoza S, Rossiter G, Ramirez L, Barkin J. Effect of nifedipine on sphincter of Oddi motor activity: studies in healthy volunteers and patients with biliary dyskinesia. Gastroenterology 1988; 95: 1050-5.
42. Sand J, Nordback I, Koskinen M, Matikainen M, Lindholm TS. Nifedipine for suspected Type II sphincter of Oddi dyskinesia. Am J Gastroenterol 1993; 88: 530-5.
43. Khuroo MS, Zargar SA, Yattoo GN. Efficacy of nifedipine therapy in patients with sphincter of Oddi dysfunction: a prospective, double-blind, randomized, placebo-controlled, cross over trial. Br J Clin Pharmacol 1992; 33: 477-85.
44. Fazel A, Li SC, Burton FR. Octreotide relaxes the hypertensive sphincter of Oddi: pathophysiological and therapeutic implications. Am J Gastroenterol 2002; 97: 612-6.
45. Guelrud M, Rossiter A, Souney P, Mendoza S, Mujica V. The effect of transcutaneous nerve stimulation on sphincter of Oddi pressure in patients with biliary dyskinesia. Am J Gastroenterol 1991; 86: 581-5.
46. Lee SK, Kim MH, Kim HJ, et al. Electroacupuncture may relax the sphincter of Oddi in humans. Gastrointest Endosc 2001; 53: 211-6.
47. Goff JS. Common bile duct sphincter of Oddi stenting in patients with suspected sphincter of Oddi dysfunction. Am J Gastroenterol 1995; 90: 586-9.
48. Rolny P. Endoscopic bile duct stent placement as a predictor of outcome following endoscopic sphincterotomy in patients with suspected sphincter of Oddi dysfunction. Eur J Gastroenterol Hepatol 1997; 9: 467-71.
49. Tarnasky PR, Palesch YY, Cunningham JT, Mauldin PD, Cotton PB, Hawes RH. Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction. Gastroenterology 1998; 115: 1518-24.
50. Fazel A, Quadri A, Catalano MF, Meyerson SM, Geenen JE. Does a pancreatic stent prevent post-ERCP pancreatitis? A prospective randomised study. Gastrointest Endosc 2003; 57: 291-4.
51. Rashdan A, Fogel EL, McHenry L Jr, et al. Improved stent characteristics for prophylaxis of post-ERCP pancreatitis. Clin Gastroenterol Hepatol 2004; 2: 322-9.
52. Kozarek RA. Balloon dilation of the sphincter of Oddi. Endoscopy 1988; 20 (Suppl. 1): 207-10.
53. Pasricha PJ, Miskovsky EP, Kalloo AN. Intrasphincteric injection of botulinum toxin for suspected sphincter of Oddi dysfunction. Gut 1994; 35: 1319-21.
54. Wehrmann T, Seifert H, Seipp M, Lembcke B, Caspary WF. Endoscopic injection of botulinum toxin for biliary sphincter of Oddi dysfunction. Endoscopy 1998; 30: 702-7.
55. Wehrmann T, Schmitt TH, Arndt A, Lembcke B, Caspary WF, Seifert H. Endoscopic injection of botulinum toxin in patients with recurrent acute pancreatitis due to pancreatic sphincter of Oddi dysfunction. Aliment Pharmacol Ther 2000; 14: 1469-77.
56. Rolny P, Geenen JE, Hogan WJ. Post-cholecystectomy patients with 'objective signs' of partial bile outflow obstruction: clinical characteristics, sphincter of Oddi manometry findings, and results of therapy. Gastrointest Endosc 1993; 39: 778-81.
57. Sherman S, Troiano FP, Hawes RH, O'Connor KW, Lehman GA. Frequency of abnormal sphincter of Oddi manometry compared with the clinical suspicion of sphincter of Oddi dysfunction. Am J Gastroenterol 1991; 86: 586-90.
58. Geenen JE, Hogan WJ, Dodds WJ, Toouli J, Venu RP. The efficacy of endoscopic sphincterotomy after cholecystectomy in patients with sphincter-of-Oddi dysfunction. N Engl J Med 1989; 320: 82-7.
59. Sherman S, Lehman GA, Jamidar P, et al. Efficacy of endoscopic sphincterotomy and surgical sphincteroplasty for patients with sphincter of Oddi dysfunction (SOD): randomized, controlled study. Gastrointest Endosc 1994; 40: A125 (abstract).
60. Toouli J, Roberts-Thomson IC, Kellow J, et al. Manometry based randomized trial of endoscopic sphincterotomy for sphincter of Oddi dysfunction. Gut 2000; 46: 98-102.
61. Thatcher BS, Sivak MV, Tedesco FJ, Vennes JA, Hutton SW, Achkar EA. Endoscopic sphincterotomy for suspected dysfunction of the sphincter of Oddi. Gastrointest Endosc 1987; 33: 91-5.
62. Botoman VA, Kozarek RA, Novell LA, Patterson DJ, Wechter DG, Neal LA. Long-term outcome after endoscopic sphincterotomy in patients with biliary colic and suspected sphincter of Oddi dysfunction. Gastrointest Endosc 1994; 40: 165-70.
63. Wehrmann T, Wiemer K, Lembcke B, Caspary WF, Jung M. Do patients with sphincter of Oddi dysfunction benefit from endoscopie sphincterotomy? A 5-year prospective trial. Eur J Gastroenterol Hepatol 1996; 8: 251-6.
64. Linder JD, Klapow JC, Linder SD, Wilcox CM. Incomplete response to endoscopic sphincterotomy in patients with sphincter of Oddi dysfunction: evidence for a chronic pain disorder. Am J Gastroenterol 2003; 98: 1738-43.
65. Bozkurt T, Orth KH, Butsch B, Lux G. Long-term clinical outcome of post-cholecystectomy patients with biliary-type pain: results of manometry, non-invasive techniques and endoscopic sphincterotomy. Eur J Gastroenterol Hepatol 1996; 8: 245-9.
66. Okolo PI 3rd, Pasricha PJ, Kalloo AN. What are the long-term results of endoscopic pancreatic sphincterotomy? Gastrointest Endosc 2000; 52: 15-9.
67. Elton E, Howell DA, Parsons WG, Qaseem T, Hanson BL. Endoscopic pancreatic sphincterotomy: indications, outcome, and a safe stentless technique. Gastrointest Endosc 1998; 47: 240-9.
68. Soffer EE, Johlin FC. Intestinal dysmotility in patients with sphincter of Oddi dysfunction. A reason for failed response to sphincterotomy. Dig Dis Sci 1994; 39: 1942-6.
69. Guelrud M, Plaz J, Mendoza S, et al Endoscopic treatment in type II pancreatic sphincter dysfunction. Gastrointest Endosc 1995; 41: 398A (abstract).
70. Sherman S. What is the role of ERCP in the setting of abdominal pain of pancreatic or biliary origin (suspected sphincter of Oddi dysfunction)? Gastrointest Endosc 2002; 56 (Suppl.): S258-66.
71. Desautels SG, Slivka A, Hutson WR, et al. Postcholecystectomy pain syndrome: pathophysiology of abdominal pain in sphincter of Oddi Type III. Gastroenterology 1999; 116: 900-5.
72. Sherman S, Troiano FP, Hawes RH, Lehman GA. Sphincter of Oddi manometry: decreased risk of clinical pancreatitis with the use of modified aspirating catheter. Gastrointest Endosc 1990; 36: 462-6.
73. Cotton PB. ERCP is most dangerous for people who need it least [Editorial]. Gastrointest Endosc 2001; 54: 425-34.
74. Williams EJ, for the Steering Committee, British Society of Gastroenterology Audit of ERCP. Risk factors for post-ERCP complication: results of a large scale prospective multicentre study. Gut 2006; 55 (Suppl. II): A6 (abstract).
75. Warshaw AL, Simeone J, Schapiro RH, Hedberg SE, Mueller PE, Ferrucci JT Jr. Objective evaluation of ampullary stenosis with ultrasonography and pancreatic stimulation. Am J Surg 1985; 149: 65-72.
76. Di Francesco V, Brunori MP, Rigo L, et al. Comparison of ultrasound-secretin test and sphincter of Oddi manometry in patients with recurrent acute pancreatitis. Dig Dis Sci 1999; 44: 336-40.
77. Boender J, van Blankenstein M, Nix GAJJ, Wilson JHP, Dees J. Endoscopic papillotomy in biliary tract pain and fluctuating cholestasis with common bile duct dilation and small gallbladder stones. Endoscopy 1992; 24: 203-7.